Congenital ichthyosis-microcephalus-tetraplegia syndrome is a very rare genetic condition present from birth. It features thick, scaly skin (ichthyosis), a smaller head size (microcephaly), and severe weakness or paralysis of all four limbs. Many people with this condition have feeding and breathing difficulties and profound developmental delay. Care is lifelong and focuses on skin care, nutritional support, respiratory support, and physical therapy, and doctors describe this as supportive management. The outlook is often serious, and some children may have a shortened life span, but care needs can vary between families.
Overview
Congenital ichthyosis-microcephalus-tetraplegia syndromeSymptoms
Congenital ichthyosis-microcephalus-tetraplegia syndrome shows from birth with thick, scaly skin, unusually small head size, and severe weakness or paralysis of all four limbs. Early signs can include breathing or feeding difficulties, seizures, joint stiffness, and profound developmental delays.
Outlook and prognosis
Living with congenital ichthyosis–microcephalus–tetraplegia syndrome often involves complex, lifelong needs. Many children have severe movement limitations, feeding and breathing challenges, and frequent infections, which can shorten life expectancy. Early coordinated care, skin management, nutrition support, and respiratory monitoring can improve comfort and stability.
Causes and risk factors
Congenital ichthyosis-microcephalus-tetraplegia syndrome results from rare, harmful changes in certain genes present from conception. Risk is higher with a family history, related parents, or when both parents are carriers; environment and lifestyle don’t cause it.
Genetic influences
Genetics is central in congenital ichthyosis–microcephalus–tetraplegia syndrome; it’s typically caused by rare, inherited variants in a single gene. Most families show autosomal recessive inheritance, so parents are usually healthy carriers. Genetic testing confirms diagnosis and informs recurrence risk.
Diagnosis
Doctors suspect congenital ichthyosis-microcephalus-tetraplegia syndrome from distinctive clinical features at birth, neurological exam, and brain and skin findings. Genetic diagnosis of congenital ichthyosis-microcephalus-tetraplegia syndrome is confirmed by targeted gene panels or exome testing, often alongside MRI and other evaluations.
Treatment and drugs
Treatment focuses on skin care, nutrition, and supportive therapies. People with congenital ichthyosis-microcephalus-tetraplegia syndrome may use emollients, keratolytic creams, and careful bathing; manage feeding, reflux, and seizures; and receive physical, occupational, and respiratory therapy. Coordinated specialist care is key.
Symptoms
Living with this rare condition can affect the skin, head growth, and muscle control from birth, shaping daily care right away. Early on, this might look like very dry, scaly skin, a smaller-than-expected head, and little or no movement in the arms and legs. These are key features of Congenital ichthyosis-microcephalus-tetraplegia syndrome. People may notice early features of Congenital ichthyosis-microcephalus-tetraplegia syndrome in the first days of life, often alongside feeding and breathing challenges.
Thick, dry, plate-like scales can cover large areas at birth. Skin may crack or feel tight, and frequent moisturizing is often needed. This dryness can make temperature control and comfort harder.
In medical terms, this is microcephaly; in everyday life, it shows up as a head that measures smaller than expected for age and sex. It often reflects differences in brain growth. Care teams may monitor development closely.
Little or no voluntary movement in both arms and legs is typical. This can make holding the head up, sitting, and moving independently difficult. This is a central feature of Congenital ichthyosis-microcephalus-tetraplegia syndrome.
A weak suck or trouble coordinating swallowing can make breastfeeding or bottle-feeding hard. Coughing or choking during feeds may occur. Some babies need temporary or long-term tube feeding for safety and nutrition.
How people usually first notice Congenital ichthyosis-microcephalus-tetraplegia syndrome?
Many families first notice something unusual during pregnancy or right after birth. Ultrasound may show a very small head (microcephaly), and at delivery babies often have tight, thickened, scaly skin that can crack, along with weak or absent movement in the arms and legs. These first signs of congenital ichthyosis‑microcephalus‑tetraplegia syndrome often prompt immediate newborn evaluation, as doctors recognize how the skin changes, small head size, and profound limb weakness fit together.
Types of Congenital ichthyosis-microcephalus-tetraplegia syndrome
Congenital ichthyosis–microcephalus–tetraplegia syndrome is a rare genetic condition. There aren’t well-established clinical variants with distinct patterns the way some other genetic disorders have. People may notice different sets of symptoms depending on their situation, but recognized subtypes are not clearly defined in the medical literature. If you are searching for types of congenital ichthyosis–microcephalus–tetraplegia syndrome, most sources describe a single clinical entity rather than separate variants.
No recognized variants
Current evidence supports one main clinical entity without distinct variants. Reported cases describe similar core features with individual differences in severity. This means types of congenital ichthyosis–microcephalus–tetraplegia syndrome are not formally separated into subgroups.
What genetics can tell you about symptoms
Some people with congenital ichthyosis‑microcephalus‑tetraplegia syndrome have variants in the VPS33B or VIPAS39 genes, which disrupt cell “cargo handling,” leading to thick, scaly skin, small head size, and severe movement limitations. These gene changes also affect nerves and eyes, causing developmental delay and vision problems.
Causes and risk factors
In congenital ichthyosis-microcephalus-tetraplegia syndrome, the main cause is a genetic change present from conception. This change may be inherited from parents or can arise as a new genetic change. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Family history raises the risk of congenital ichthyosis-microcephalus-tetraplegia syndrome, and recurrence is more likely when parents carry the same change. Pregnancy health, infections, and early nutrition do not cause the syndrome, but they can shape severity and complications.
Environmental and biological risk factors
Congenital ichthyosis-microcephalus-tetraplegia syndrome begins before birth, so risk largely reflects what happens very early in pregnancy. Doctors often group risks into internal (biological) and external (environmental). At present, researchers have not identified specific environmental risk factors for congenital ichthyosis-microcephalus-tetraplegia syndrome, and most information comes from broader studies of fetal brain and skin development. The points below outline what is known and what remains uncertain.
Critical steps in brain and skin formation occur in the first weeks of pregnancy. Biological disruptions during this window can shape risk. These early changes are usually set long before birth.
Uncontrolled diabetes, severe thyroid disease, or major autoimmune illness can alter fetal development. These conditions have not been shown to cause this syndrome.
Infections such as rubella, cytomegalovirus, or Zika can affect fetal brain growth. They have not been proven risk factors for this syndrome, but they can resemble some findings seen in affected newborns.
High-dose radiation, heavy metals like lead or mercury, and some industrial solvents can disrupt fetal development. No consistent link with congenital ichthyosis-microcephalus-tetraplegia syndrome has been shown.
Genetic risk factors
For many families, risk hinges on inherited gene changes rather than anything in day-to-day life. Some risk factors are inherited through our genes. Understanding the genetic causes of Congenital ichthyosis-microcephalus-tetraplegia syndrome can help families plan for testing and future pregnancies. In this condition, changes in genes that guide early skin and brain development are the key driver.
Autosomal recessive pattern: In reported families, this syndrome is typically inherited when a child receives two non-working copies of the same gene. Each parent carries one copy but usually has no symptoms. This pattern has been described in Congenital ichthyosis-microcephalus-tetraplegia syndrome.
Carrier parents: When both partners are carriers of the same variant, each pregnancy has a 25% (1 in 4) chance to be affected. There is also a 50% (1 in 2) chance the child will be a healthy carrier. Siblings can therefore have different outcomes.
Affects all sexes: Because the genes are on non-sex chromosomes, males and females face similar risk. Congenital ichthyosis-microcephalus-tetraplegia syndrome is not known to follow an X-linked pattern.
Shared ancestry (consanguinity): Parents who are related or from a small, isolated community are more likely to carry the same rare variant. This raises the chance of a child with Congenital ichthyosis-microcephalus-tetraplegia syndrome. Genetic counseling can help clarify personal risk.
Variable expression: Features and severity can differ, even among siblings with the same variants. Some may have more profound movement limitations than others, or slightly different skin findings. This variation does not change the inheritance pattern.
New (de novo) variants: A single new variant in one gene copy is usually not enough to cause a recessive syndrome. Two disease-causing changes—one on each copy—are typically required. Most unexpected diagnoses still reflect two carrier parents.
Skin–brain pathways: The underlying gene changes disrupt pathways that help form the skin barrier and support brain growth. This helps explain the mix of ichthyosis, microcephaly, and severe motor involvement. These mechanisms are central to Congenital ichthyosis-microcephalus-tetraplegia syndrome.
Molecular confirmation: Gene panel, exome, or genome testing can identify the responsible variants in many families. Confirming the exact change enables carrier testing, prenatal diagnosis, or IVF with embryo testing in future pregnancies. This can clarify recurrence risk for Congenital ichthyosis-microcephalus-tetraplegia syndrome.
Family history patterns: If one child is affected, full siblings have higher chances of being carriers. Testing relatives can map who carries the variant and who is at risk for affected children. Findings guide tailored counseling for the family.
Lifestyle risk factors
This syndrome is genetic; lifestyle habits do not cause it, but daily routines can influence symptoms, comfort, and complications. Here are practical ways how lifestyle affects Congenital ichthyosis-microcephalus-tetraplegia syndrome in day-to-day care. Thoughtful choices around skin care, nutrition, movement, and positioning can reduce infections, pressure injuries, and breathing problems. The following lifestyle risk factors for Congenital ichthyosis-microcephalus-tetraplegia syndrome focus on elements families can modify with clinical guidance.
Daily emollients and keratolytics soften scales and reduce cracks that invite infection. Avoiding harsh soaps and vigorous scrubbing prevents additional barrier damage.
Short, lukewarm baths or soaks help scale shedding without excessive water loss. Prolonged hot bathing can worsen dryness, fissuring, and discomfort.
Higher protein and calorie intake may be needed due to rapid skin turnover. Poor intake can slow wound healing, impair growth, and raise pressure-injury risk.
Adequate fluids support skin hydration and temperature tolerance in ichthyosis. Dehydration increases scaling, itching, and constipation.
Risk prevention
Congenital ichthyosis-microcephalus-tetraplegia syndrome is a genetic condition, so we can’t prevent the condition itself, but we can lower the chance of complications and protect day-to-day health. Recognizing early symptoms of Congenital ichthyosis-microcephalus-tetraplegia syndrome helps care teams act quickly with supportive treatments. Prevention is about lowering risk, not eliminating it completely. With steady routines and regular follow-up, families can help their child stay safer, more comfortable, and better supported.
Use gentle bathing, fragrance-free moisturizers, and barrier ointments to keep skin soft and intact. This helps prevent cracks, infections, and discomfort.
Keep nails trimmed, clean hands often, and treat any skin breaks early. Watch for redness, warmth, swelling, or fever and seek care promptly.
People with this syndrome can overheat or chill more easily due to skin changes. Dress in breathable layers, avoid hot environments, and offer fluids regularly.
Lubricating drops or ointments can protect the surface of the eyes when lids don’t close fully. Regular eye checks help prevent irritation or scratches.
Transmission
Congenital ichthyosis-microcephalus-tetraplegia syndrome is not contagious and cannot be caught from someone else; it is present from birth due to changes in certain genes. In many families, it happens when a child receives one changed copy of the same gene from each parent; carriers are healthy, but when both parents are carriers, each pregnancy has a 25% (1 in 4) chance of an affected child, a 50% chance the child will be a carrier, and a 25% chance of inheriting neither change. A genetics professional can explain how Congenital ichthyosis-microcephalus-tetraplegia syndrome is inherited in your family and discuss options such as carrier testing or prenatal testing.
When to test your genes
Consider genetic testing if a newborn shows thickened scaly skin, very small head size, and profound movement weakness, or if there is a family history of similar findings. Testing helps confirm the diagnosis early, guide skin care, nutrition, seizure monitoring, mobility support, and inform recurrence risks. Parents planning another pregnancy may pursue carrier testing and prenatal options.
Diagnosis
For many families, the first clues come at birth or soon after, when a baby has very dry, scaly skin along with a smaller-than-expected head size and movement difficulties. Doctors look at this full picture to guide the diagnosis of Congenital ichthyosis-microcephalus-tetraplegia syndrome. Early and accurate diagnosis can help you plan ahead with confidence. From there, testing focuses on confirming the cause and understanding what care is needed next.
Doctors look for a consistent pattern—severe skin scaling, small head size, and arm and leg weakness or stiffness. Features present from birth point toward a genetic condition.
Specialists check muscle tone, reflexes, posture, feeding, and breathing control. Findings like spasticity and limited movement help define how the nervous system is affected.
MRI takes detailed pictures of brain structure and growth. Imaging findings can support a brain development problem and help rule out other causes.
A dermatology exam reviews the pattern of scaling, involvement of palms and soles, nails, and hair. These details help distinguish types of congenital ichthyosis.
Stages of Congenital ichthyosis-microcephalus-tetraplegia syndrome
Congenital ichthyosis-microcephalus-tetraplegia syndrome does not have defined progression stages. Signs are present from birth and usually reflect a fixed pattern of severe skin changes, very small head size, and limited movement, rather than a condition that unfolds step by step. Different tests may be suggested to help confirm the diagnosis and guide day-to-day care planning. Because early symptoms of Congenital ichthyosis-microcephalus-tetraplegia syndrome appear at or soon after birth, evaluation typically includes a careful physical exam, input from skin and nerve specialists, brain imaging if indicated, and genetic testing to identify the underlying cause.
Outlook and prognosis
Looking ahead can feel daunting, but most families want a clear sense of how life may unfold with congenital ichthyosis–microcephalus–tetraplegia syndrome. This ultra-rare condition affects skin, brain growth, and movement from birth, so early symptoms of congenital ichthyosis–microcephalus–tetraplegia syndrome often include thick, scaly skin, a very small head size, feeding troubles, and profound muscle weakness. Severe breathing problems, temperature instability, and infections can occur in infancy, and these early complications largely shape the outlook.
Prognosis refers to how a condition tends to change or stabilize over time. For many children with congenital ichthyosis–microcephalus–tetraplegia syndrome, development is significantly limited, with little to no independent movement and complex medical needs. Some infants face life-threatening complications in the newborn period; among those who survive infancy, ongoing issues with seizures, nutrition, skin infections, and respiratory health are common. Exact survival data are scarce because the syndrome is so rare, but published reports suggest high infant mortality and shortened life span, especially when breathing or feeding difficulties are severe.
The outlook is not the same for everyone, but the best outcomes reported involve rapid, coordinated care for skin, breathing, feeding, and seizure control. Good skin care can lower infection risk, feeding support can prevent malnutrition, and proactive respiratory care may reduce hospitalizations. Genetic testing can sometimes provide more insight into prognosis, particularly when different gene changes are linked to milder or more severe courses. Talk with your doctor about what your personal outlook might look like, and ask how to plan for comfort-focused care alongside treatments aimed at preventing complications.
Long-term effects
Congenital ichthyosis-microcephalus-tetraplegia syndrome tends to have lifelong effects that touch movement, thinking, and skin health. Long-term effects vary widely, and the course can differ even among people with the same diagnosis. For many, this means significant care needs across childhood and adulthood, with close medical follow-up. The long-term picture often includes complications linked to immobility, feeding challenges, and recurrent infections.
Tetraplegia or near-complete limb weakness usually persists over time. This can lead to joint contractures and scoliosis as the body grows.
Cognitive and communication abilities often remain significantly limited. Many people require full support for learning and daily activities.
Ichthyosis tends to be lifelong with thick, dry, scaling skin. Skin cracks can raise the risk of infections and heat-related strain.
Swallowing difficulty can make weight gain and growth hard to maintain. Aspiration into the lungs may contribute to chest infections over time.
How is it to live with Congenital ichthyosis-microcephalus-tetraplegia syndrome?
Living with congenital ichthyosis–microcephalus–tetraplegia syndrome often means around-the-clock care, with daily skin routines to manage dryness and scaling, assisted feeding and positioning, and full support for mobility and communication. Many families coordinate multiple specialists—neurology, dermatology, physical and occupational therapy, nutrition—and rely on adaptive equipment for comfort and safety. For those around the child, the impact can be profound: caregivers learn medical tasks, adjust work and home life, and build a support network to prevent burnout while celebrating small gains. Community resources, respite services, and clear care plans can ease daily strain and help everyone focus on comfort, connection, and quality of life.
Treatment and drugs
Treatment for Congenital ichthyosis–microcephalus–tetraplegia syndrome focuses on easing symptoms and supporting daily function, since there’s no cure yet. Care is usually team-based and long term, combining intensive skin care (regular moisturizing with thick emollients, keratolytic creams as advised, gentle bathing, and careful infection prevention), physical and occupational therapy to manage muscle stiffness and movement limits, and nutritional support if feeding or growth is affected. Seizures, spasticity, and sleep or breathing issues are managed with medicines when needed, and a doctor may adjust your dose to balance benefits and side effects. Eye protection and lubrication help with dry or irritated eyes, while hearing and vision are monitored so aids can be provided early. Supportive care can make a real difference in how you feel day to day, and regular follow-up helps the team adapt treatment as needs change.
Non-drug treatment
Daily care focuses on comfort, mobility, feeding, and breathing support at home so families can manage daily needs more easily. Alongside medicines, non-drug therapies often carry much of the day-to-day care. In the newborn period, early symptoms of Congenital ichthyosis-microcephalus-tetraplegia syndrome may include tight, dry skin and very limited movement, so hands-on therapies start early. Plans are tailored to each child and adjusted as needs change over time.
Liberal use of bland moisturizers helps soften thick, dry skin and reduce cracking. Gentle, regular application after bathing seals in moisture and improves comfort. Consistent routines can also lower skin infection risk in Congenital ichthyosis-microcephalus-tetraplegia syndrome.
Short, lukewarm baths followed by quick moisturizing can reduce itching and tightness. A home humidifier can ease dryness, especially in winter or dry climates.
Soft, damp cotton layers over moisturizer can hydrate stubborn areas and calm irritation. This technique is especially helpful during skin flares or after bathing.
Frequent lubrication with non-medicated moisture shields, moisture goggles, or nighttime eye chambers can help protect exposed eyes. Sunglasses and avoiding wind drafts reduce irritation outdoors.
Your genes may have an impact on how drugs work for you
Medicines for congenital ichthyosis–microcephalus–tetraplegia syndrome can work differently depending on gene changes that affect skin barriers, nerve signaling, and how the body processes drugs. Genetic testing can guide safer dosing, reduce side effects, and suggest alternative treatments when standard options fall short.
Pharmacological treatments
Treatment for congenital ichthyosis-microcephalus-tetraplegia syndrome focuses on easing skin symptoms, managing muscle stiffness, and preventing infections or other complications. Drugs that target symptoms directly are called symptomatic treatments. While medicines don’t change the underlying condition, they can ease problems that show up early, such as painful skin and muscle stiffness—these are among the early symptoms of congenital ichthyosis-microcephalus-tetraplegia syndrome. Choices are tailored to skin needs, muscle tone, and any infections or seizures.
Urea 10–20% and lactic acid 5–12% creams can soften thick scales and reduce cracking. Applying after a lukewarm bath can lock in moisture and improve comfort.
Mupirocin (US) or fusidic acid (EU) can clear small, localized skin infections. Wider or deeper infections may need oral antibiotics like cephalexin or dicloxacillin.
Acitretin or isotretinoin may be used by specialists for severe scaling when topical care isn’t enough. Dosing may be increased or lowered gradually to balance skin benefits with side effects.
Cetirizine or loratadine can reduce itch without making most people drowsy. If nighttime itch disrupts sleep, hydroxyzine may help but can cause sleepiness.
Genetic influences
Genetic factors appear to play a central role in Congenital ichthyosis-microcephalus-tetraplegia syndrome. Reports from affected families suggest an autosomal recessive pattern, where a child develops the condition after inheriting two changed copies of the same gene—one from each parent. In this situation, parents are typically healthy carriers; when both are carriers, each pregnancy has a 25% chance for a child to be affected, a 50% chance for an unaffected carrier, and a 25% chance to inherit neither change. Severity can vary even within the same family, so the early symptoms of Congenital ichthyosis-microcephalus-tetraplegia syndrome may not look identical from one child to another. DNA testing can sometimes identify these changes, and genetic testing for Congenital ichthyosis-microcephalus-tetraplegia syndrome may help confirm the diagnosis and clarify risks for relatives. Knowing the genetic pattern can help you and your clinicians discuss recurrence risk, plan pregnancies, and consider options for relatives who want testing.
Is Congenital ichthyosis-microcephalus-tetraplegia syndrome genetic?
Genetics is central in congenital ichthyosis–microcephalus–tetraplegia syndrome; it’s typically caused by rare, inherited variants in a single gene. Most families show autosomal recessive inheritance, so parents are usually healthy carriers. Genetic testing confirms diagnosis and informs recurrence risk.
Pharmacogenetics—how genetics influence drug effects
Because this condition is genetic, medicines focus on easing day-to-day symptoms—moisturizing and softening the skin, managing spasticity, and treating seizures if they occur—rather than correcting the underlying change. Differences in the genes that control liver enzymes can influence how people respond to common treatments such as pain relievers, muscle relaxants, or anti-seizure medications, so dose and drug choice may need extra tailoring. Genetic testing can sometimes identify how your body processes certain medications, which can guide dosing and help avoid side effects. For creams and ointments, a fragile skin barrier can increase absorption, so gentler formulations and careful monitoring are important to reduce irritation or systemic effects. If systemic retinoids or medicines for muscle stiffness are considered, plans are individualized and closely monitored, with genes only part of the picture alongside weight, liver and kidney function, and nutrition. Ask your care team whether pharmacogenetic testing could guide medication options for Congenital ichthyosis-microcephalus-tetraplegia syndrome, especially for anti-seizure therapies or pain control.
Interactions with other conditions
Skin and nerve involvement in this ultra-rare disorder can change how other illnesses show up and how they’re managed. In Congenital ichthyosis-microcephalus-tetraplegia syndrome, the fragile, scaly skin barrier makes bacterial and fungal skin infections more likely, and eczema or allergies can flare more easily on already dry skin. Doctors call it a “comorbidity” when two conditions occur together, and respiratory infections are a common example here because swallowing problems and weak cough can lead to aspiration and pneumonia. Seizures may occur alongside the condition, and medicines used for seizures or muscle stiffness can interact with treatments for reflux, constipation, or skin care, so plans often need careful coordination. Poor weight gain can compound everything: infections are harder to fight, skin heals more slowly, and pressure areas from limited movement can break down and get infected. Someone might notice their symptoms flare when another condition is active, for example, a cold triggering more seizures or worsening feeding, so early contact with the care team during any illness is important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with unusually tight, scaly skin and very small head size who struggled to move their arms and legs. Midwives noted fragile skin that cracked soon after birth, while families remembered babies who needed constant ointments and careful wrapping just to keep comfortable. Sadly, many of these infants faced serious infections or breathing problems early in life, and records were often brief.
First described in the medical literature as a severe form of congenital ichthyosis linked with a markedly small head and profound limb weakness, the condition was initially grouped with other rare newborn skin disorders. Early doctors focused on what they could see and feel at the bedside—thickened skin plates, stiffness, and little spontaneous movement—without a clear sense of the underlying cause. Over time, descriptions became more consistent, noting that these babies not only had scaly skin from birth but also signs of limited brain growth and near-paralysis affecting all four limbs.
From early theories to modern research, the story of Congenital ichthyosis-microcephalus-tetraplegia syndrome shows how observation led to clearer definitions. As medical science evolved, case reports began to separate this pattern from other ichthyosis conditions and from neurologic syndromes that did not involve the skin. Specialists recognized that the combination of three features—congenital ichthyosis, microcephaly, and profound limb weakness—formed a distinct clinical picture rather than a coincidence of unrelated problems.
In recent decades, knowledge has built on a long tradition of observation. Detailed photographs, standardized neurologic exams, and skin biopsies helped confirm that early symptoms of Congenital ichthyosis-microcephalus-tetraplegia syndrome were present right at birth and tended to follow a similar course. Advances in genetics then connected scattered family stories across countries, showing that this syndrome followed inherited patterns rather than being caused by infections or pregnancy complications. Although it remains very rare, clinicians now recognize it earlier, provide focused supportive care from day one, and offer families clearer counseling about what to expect.